European Journal of Molecular & Clinical Medicine

Abstract

Aim: To evaluate the improvement in visual acuity and central macular thickness after combination therapy of laser photocoagulation with single intravitreal bevacizumab injection in macular edema secondary to BRVO.
Material & Methods: This was a clinical trial study of 30 patients diagnosed with macular edema secondary to BRVO. Group A (n=15) was treated with laser photocoagulation therapy in combination with intravitreal bevacizumab injection, while Group B (n=15) was treated with laser photocoagulation therapy alone.
Results: There was no sig­nificant difference between the two groups with regard to sex (P=1.00). A significant difference in visual acuity between the two groups at 3-month follow-up (P=0.010) can be observed.No significant difference in macular thickness between the two groups was observed (P=0.772).
Conclusion: Laser photocoagulation combined with a single intravitreal bevacizumab has a substantial effect on increasing visual acuity in macular edema secondary to BRVO.